Metraipolis › archive › dc_4921953a0ac4

Enhance therapeutic efficacy of BiTE (HER2/CD3) for HER2- positive tumors through in vivo expression — Europe PMC PMID:40919374

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40919374
DOI
10.1016/j.ijpx.2025.100375
License (as archived)
solo-consultazione
Archived
2026-11-10T15:15:24.585Z
SHA-256 of the archived text
5c9e1c4933bc1176e913d4562b6292a787d3b189d6d271bd4bc32bb0f9ab87ea
Stable URL of this page
https://metraipolis.com/documento/dc_4921953a0ac4

How to cite

Enhance therapeutic efficacy of BiTE (HER2/CD3) for HER2- positive tumors through in vivo expression — Europe PMC PMID:40919374 — Europe PMC (en), https://europepmc.org/article/MED/40919374 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4921953a0ac4 (Metraipolis archive dc_4921953a0ac4, sha256 5c9e1c4933bc1176e913d4562b6292a787d3b189d6d271bd4bc32bb0f9ab87ea)
BibTeX
@misc{dc4921953a0ac4,
  title = {Enhance therapeutic efficacy of BiTE (HER2/CD3) for HER2- positive tumors through in vivo expression — Europe PMC PMID:40919374},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40919374},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4921953a0ac4; sha256 5c9e1c4933bc1176e913d4562b6292a787d3b189d6d271bd4bc32bb0f9ab87ea},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40919374. Agents can read the archived copy with the MCP tool read_document.